All News

Patients and caregivers can only make truly informed decisions about end-of-life care when they understand the natural process of dying, says Tani Bahti, RN.

Trained therapy animals help patients relieve stress and anxiety during treatment.

Data from the phase 3 EMILIA trial shows progression-free survival benefit in metastatic HER2-positive breast cancer patients.

Two new targeted therapies, which each focus on a different way to block cancer growth signaling, delayed disease progression in advanced melanoma patients.

A new drug regimen that combines Treanda (bendamustine) and Rituxan (rituximab) has been shown to more than double progression-free survival time.

Afatinib significantly improves progression-free survival among patients with advanced lung cancer that harbors certain genetic mutations compared with standard chemotherapy.